Cargando...
Carrier Cells for Delivery of Oncolytic Measles Virus into Tumors: Determinants of Efficient Loading
Oncolytic measles virus (OMV) is a promising antitumor agent. However, the presence of anti-measles neutralizing antibodies (NAbs) against the hemagglutinin (H) protein of OMV is a major barrier to the therapeutic application of OMV in clinical practice. In order to overcome this challenge, specific...
Gardado en:
| Publicado en: | Virol Sin |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer Singapore
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6178551/ https://ncbi.nlm.nih.gov/pubmed/29767404 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12250-018-0033-2 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|